Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rafael Amado currently holds 57,022 shares of Adaptimmune Therapeutics PLC (ADAP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rafael Amado has been a net seller of ADAP stock. They have purchased $0 and sold $2.6M worth of shares.
Rafael Amado's most recent insider trade was on Apr 6, 2026, when they sold 2,739 shares at $20.45 per share.
Rafael Amado serves as Executive at Adaptimmune Therapeutics PLC (ADAP). They have executed 43 insider transactions totaling $2.6M over their tenure at the company.
Rafael Amado holds the position of Executive at Adaptimmune Therapeutics PLC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Rafael Amado has shown a selling trading pattern, with $0 in total purchases and $2.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rafael Amado was on Oct 7, 2020, when they sold $651.6K worth of ALLO shares. This transaction involved 16,538 shares at $39.40 per share.
Rafael Amado currently owns 57,022 shares of Adaptimmune Therapeutics PLC (ADAP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rafael Amado's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rafael Amado has 43 Form 4 filings on record as an insider at Adaptimmune Therapeutics PLC.
Set alerts for Rafael Amado and 40,000+ other insiders.